Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
Israel · Delayed Price · Currency is ILS · Price in ILA 20.90
-0.10 (-0.48%)
At close: Feb 20, 2026
TLV:TKUN Market Cap
TLV:TKUN has a market cap or net worth of 17.76 million as of February 20, 2026. Its market cap has decreased by -47.25% in one year.
Market Cap
17.76M
Enterprise Value
26.01M
Revenue
34.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.90
Market Cap Chart
Since March 17, 2010, TLV:TKUN's market cap has decreased from 22.23B to 17.76M, a decrease of -99.92%. That is a compound annual growth rate of -36.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 17.76M | -11.81% |
| Dec 31, 2025 | 20.14M | -28.70% |
| Dec 31, 2024 | 28.24M | 10.79% |
| Dec 31, 2023 | 25.49M | -41.22% |
| Dec 29, 2022 | 43.36M | -59.63% |
| Dec 30, 2021 | 107.40M | -42.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 125.18B |
| Danel (Adir Yeoshua) | 2.68B |
| BrainsWay | 1.55B |
| Kamada | 1.54B |
| Nextage Therapeutics | 26.25M |
| XTL Biopharmaceuticals | 25.55M |
| Evogene | 24.91M |
| Bio-View | 22.65M |